Lypro Biosciences' Acquisition

Lypro Biosciences was acquired by Cerenis Therapeutics on November 08, 2017.

Lypro Biosciences is a specialty biopharma company whose technology addresses the adverse effects arising from the insoluble nature of certain hydrophobic drugs.…

Articles about Lypro Biosciences' Acquisition: